Furthermore, it was found that hematopoietic stem cell clones with pathogenic mutations in the methyltransferase-coding gene DNMT3A repeatedly expanded in the course of the treatment in MBD4 deficient AML patients, suggesting that the loss of MBD4 drives clonal hematopoiesis (139). This evidence concerns the gene MBD4 and acute myeloid leukemia.